Long Paper JG
Long Paper JG
Long Paper JG
By James Gillespie
Abstract
In this paper I argue that the mind altering medication used in treating mental disorders
can cause significant changes in the self, which is often overlooked in the clinical setting.
Furthermore these changes are in many cases not worth the improvement in condition that the
drugs afford. From this perspective I will investigate several of the most common drug types in
psychiatry as well as propose a method of cost-benefit analysis for prescription.
Introduction
Todays psychiatric patient is unprecedentedly medicated. There is just about no
condition for which a drug cannot be prescribed, and if there were it can be imagined that one
would quickly be found to fill the void. This deluge of medication has allowed treatment of
disorders had previously been life ruining and reintegration of otherwise uncontrollable
individuals into society. But the medication used in psychiatry is not the same as that used in
other fields of medicine. The mind is where the essence of a person resides it is who we are.
Medication that alters mental states therefor must provoke unique ethical questions beyond the
typical evaluation of risk of harm and discomfort. And yet this discussion is almost entirely
absent in the clinical psychiatry world. Altering the self is not something to be taken lightly. I
hope to show the significance of this in the following sections
agent independent from the rest of the world I think therefor I am. Avicenna proposed in his
floating man experiment that the self was whatever was left over if a person was totally
deprived of all senses. Hume on the other hand characterized the self as simply a collection of
different perceptions which succeed one anotherin perpetual flux and movement. Daniel
Dennett took that a step further, characterizing the self as convenient fiction whos only purpose
is to be used as a narrative center. Despite these seemingly infinite views, there are some
commonalities. Almost all definitions of the self-include some combination of the following:
memory, personality, beliefs, behaviors, and a center of consciousness that endures over time.
Even Dennetts convenient fiction is the imaginary entity that experiences those phenomena.
Returning to the topic of this paper, we can for now avoid the problem of finding a perfect
definition of the self. Due to the sheer number of drugs now prescribed as well as their wide
range of effects, its not really important which concept of the self one settles on. No matter the
concept, there is sure to be a drug that impacts it. Moving forward I will stick with my
symptomatic list for easy reference.
This process is invaluable because it allows for the possibility of internally driven growth. The
reformed criminal, the lazy student turned hard worker, the selfish jerk turned caring friend, all
chose to change themselves and came out better for it. Internally driven self-improvement is a
gradual process that is solely the prerogative of the person undergoing it (although it likely will
impact others) and does not impede coherence. By maintaining a coherent self one is allowed
consistent insight into their own inner workings, which leads to a healthier, more fulfilling
existence. And it affords the individual a good deal of self-control, which is beneficial not just to
them, but to those around them as well.
allows for specific, controlled mood uplift with seemingly no strings attached. However, as Paul
Biegler points out, the mood control is itself the string. He explains that antidepressant use
affords the patient no opportunity for insight into how to manage the stressors of their life that
often trigger depressive episodes. In fact, it can harm the patient by reducing their autonomy by
controlling their mood externally.
Unlike anti-depressants, benzodiazepines are broad in effect. They work by enhancing the
effect of GABA, the brains primary inhibitory neurotransmitter. By increasing this inhibitory
action, benzodiazapines effectively depress action across the brain, leading to a host of effects
including sedation, confusion, amnesia, cognitive impairment, depersonalization (a feeling of
watching oneself act without being able to control anything), dissociation (a detachment from
experiencing reality) and many more. Because of their depressive properties benzodiazapines are
most commonly used to treat anxiety disorders, but their wide effects also lend themselves to
many other areas of medication. The list of effects may seem severe, but these drugs are almost
always prescribed short term as an immediate response to anxiety attacks. And lasting effects of
this are very rare. However it cannot be denied that during their short term application
benzodiazapines have major effects on the self. And like antidepressants these can serve as a
crutch rather than treating the underlying cause. In fact, even worse they dont really treat the
fear reaction either. Rather they dampen the response by sedating and dissociating the patient
from the panic theyre experiencing. But the fear is still there and the patient has made no
progress in overcoming it.
Antipsychotics are the classic mental disorder drugs and most have been used for many
decades. Theyre used to treat psychosis, which is usually described as a break with reality
(delusions, hallucinations, etc). Their most common application is schizophrenia. Antipsychotics
work by blocking the brains dopamine (yet another neurotransmitter) receptors. Psychotic
episodes typically involve an excessive release of dopamine in the mesolimbic pathway, so these
drugs suppress those. However this is not even close to the only area dopamine is involved, so it
should come as no surprise that antipsychotics come with their share of off-target effects. They
can cause drowsiness, restlessness, memory loss, sedation of emotion, and behavioral changes.
And unlike benzodiazepines, antipsychotics are usually taken long term because they are
intended to proactively prevent episodes. Antipsychotics also do not always actually treat the
disease, instead blunting the symptoms. In many cases patients will still experience delusions
and hallucinations but lack the motivation to act upon them. So the patient is not really a version
of their healthy self on antipsychotics. Instead the patient is a version of themselves with both a
mental disorder and all the effects of the drugs layered on top. This makes antipsychotics not
only an undesirable method of self change, but also a non-optimal direction to change towards.
Mood stabilizers are a class of drugs not yet fully understood. The exact mechanism of
their action is unknown, but their primary effect is a reduction in the magnitude of mood swings.
Because of this their primary use is treatment of mood disorders like bipolar disorder. Despite the
name, many mood stabilizers will only act to improve manic or depressive episodes, not both.
And the effect of each mood stabilizer varies greatly between individuals, which often leads to a
patient needed to go through several drugs before finding one that works for them. As with
antipsychotics these do not treat the underlying disorder patients still experience mood swings,
theyre just lesser in magnitude. Normal, non-pathological mood swings are also dampened
along with the disorder. Mood stabilizers are also accompanied by a moderate level of off target
effects including impaired memory, fatigue, and difficulty concentrating. I think it is clear that at
least in regards to memory and mood these drugs have a significant effect on the self. By
dampening the effect of the patients moods, both healthy and pathological, mood stabilizers
inhibit the ability of the self to naturally develop through emotional responses. Instead, during
the course of treatment, they artificially shift the self from one of uncontrollable extremes to one
of uncontrollable moderation.
reflective and leads to a more fulfilling life. Beyond even the method of change, there is also the
risk that the patient may not like the destination. If a patient is unhappy with who the medication
turns them into, what was the point of the self change in the first place?
many mentally ill patients. Autistics in particular often report being just as satisfied with their
lives as non-pathological individuals. It is even possible for a disorder to become a valued part
of the self. Consider an artist who suffers from moderate manic episodes. Theyre not strong
enough for his life to be in danger, but it does allow him bursts of creativity and productivity.
Over time the artist, even between episodes, comes to value and even rely on his disorder. I think
it is clear in both of these cases that the subjects (they cant really be called patients) would not
benefit from medication, but would in fact suffer from the self change it would force upon them.
For the most part I have ignored physical side effects, but it should be noted that is severe
enough they can also have a mental impact through the trauma they inflict. When combined with
the mental side effects often the treatment can be as bad or worse than the disease, which I think
makes treatment unacceptable. Finally, while considering all of the positive benefits of the drug,
one must weigh this against the magnitude of self change that the drug will impart. All of this
varies between drugs and individuals, so there is no clear answer. But the general idea is that if a
drug is changing the core of who a person is their beliefs, personality, priorities, etc then it
ought to be offering a lot of relief from a severe disease.
References
"Mental Health Medications." NIMH RSS. National Institutes of Health.
<http://www.nimh.nih.gov/health/publications/mental-health-medications/index.shtml>.
Biegler, Paul. "Autonomy and Ethical Treatment in Depression." Bioethics 24.4 (2010):
179-89.
David DeGrazia, "Prozac, Enhancement, and Self-Creation," Hasting Center
Dennett, Daniel (1992) The Self as a Center of Narrative Gravity in F. Kessel, P. Cole and
D. Johnson, eds, Self and Consciousness: Multiple Perspectives, Hillsdale, NJ
Gaynesford, M. de I: The Meaning of the First Person Term, Oxford, Oxford University
Press, 2006.
Report 30, no. 2 (2000): 34-4
Sententia, Wrye (2004). "Neuroethical Considerations: Cognitive Liberty and Converging
Technologies for Improving Human Cognition". Annals of the New York Academy of Sciences
1013: 223
Seyyed Hossein Nasr and Oliver Leaman (1996), History of Islamic Philosophy, p. 315,
Routledge, ISBN 0-415-13159-6